PURR Key Statistics, Chart & Performance
The current stock price of PURR is 4.63 USD. In the past month the price increased by 34.2%.
PURR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PURR.
PURR Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PURR Forecast & Estimates
8 analysts have analysed PURR and the average price target is 6.71 USD. This implies a price increase of 44.85% is expected in the next year compared to the current price of 4.63.
PURR Ownership
PURR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.32 | 394.585B | ||
| AMGN | AMGEN INC | 16.18 | 202.372B | ||
| GILD | GILEAD SCIENCES INC | 16.51 | 188.186B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.73 | 119.469B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.25 | 82.007B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.21 | 42.275B | ||
| INSM | INSMED INC | N/A | 31.892B | ||
| NTRA | NATERA INC | N/A | 29.062B | ||
| BIIB | BIOGEN INC | 12.42 | 28.432B | ||
| INCY | INCYTE CORP | 12.5 | 21.405B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PURR
Company Profile
Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
Company Info
HYPERLIQUID STRATEGIES
477 Madison Avenue, 22nd Floor
New York City NEW YORK US
Employees: 0
Phone: 12128834330
HYPERLIQUID STRATEGIES / PURR FAQ
What does PURR do?
Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
What is the current price of PURR stock?
The current stock price of PURR is 4.63 USD. The price decreased by -5.32% in the last trading session.
Does PURR stock pay dividends?
PURR does not pay a dividend.
What is the ChartMill technical and fundamental rating of PURR stock?
PURR has a ChartMill Technical rating of 4 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.